Michelson Diagnostics Chosen To Participate In Future Health Mission 2011

Between more than 70 applicants, Michelson Diagnostics Ltd, the Orpington, UK-based developer and manufacturer of laser scanners for use in non-melanoma skin cancer diagnosis & treatment is chosen to participate in the Future Health Mission 2011 to the USA. The event is taking place in San Francisco along with the annual J.P. Morgan Healthcare Investing Conference in early January.

Regarding to the mission organizers, the Future Health Mission 2011 may provide the businessmen responsible for these 20 growing healthcare technology companies with the opportunity to connect with key people from the US's top technology businesses. Those companies which are the most successful in the UK will manage a conference to meet the media from all over the world as well as investors and potential partners.

For more info. please visit:

Michelson Diagnostics Chosen To Participate In Future Health Mission 2011